Global Hematological Cancers Market Professional Survey Report 2018

January 2018 | 111 pages | ID: GA33677AF7CEN
QYResearch

Abstracts

This report studies Hematological Cancers in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Karyopharm Therapeutics
• Johnson & Johnson
• Roche Diagnostics A/S
• AbbVie
• Novartis
• Kite Pharma
• Celgene Corporation
• Abbott Laboratories
• Beckman Coulter
• HemoCue AB
• C. R. Bard
• Siemens AG
• Sysmex
• Mindray Medical International Limited
• Bio-Rad Laboratories
• The Medicine Company
• Pharmacyclics
• Horiba
• DiagnoCure Inc.
• Astellas Pharma US

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Pharmacological Therapies
• Stem Cell Transplantation
• Surgery and Radiation Therapy
• Anemia Treatment
• Thrombosis Treatment
• Neutopenia Treatment
• Symptomatic treatment

By Application, the market can be split into

• Epidemiology
• Pathophysiology of Leukemic Stem Cells
• Kidney Diseases
• Genetic Diseases
• Other Diseases

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Hematological Cancers Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF HEMATOLOGICAL CANCERS

1.1 Definition and Specifications of Hematological Cancers
  1.1.1 Definition of Hematological Cancers
  1.1.2 Specifications of Hematological Cancers
1.2 Classification of Hematological Cancers
  1.2.1 Pharmacological Therapies
  1.2.2 Stem Cell Transplantation
  1.2.3 Surgery and Radiation Therapy
  1.2.4 Anemia Treatment
  1.2.5 Thrombosis Treatment
  1.2.6 Neutopenia Treatment
  1.2.7 Symptomatic treatment
1.3 Applications of Hematological Cancers
  1.3.1 Epidemiology
  1.3.2 Pathophysiology of Leukemic Stem Cells
  1.3.3 Kidney Diseases
  1.3.4 Genetic Diseases
  1.3.5 Other Diseases
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF HEMATOLOGICAL CANCERS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hematological Cancers
2.3 Manufacturing Process Analysis of Hematological Cancers
2.4 Industry Chain Structure of Hematological Cancers

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF HEMATOLOGICAL CANCERS

3.1 Capacity and Commercial Production Date of Global Hematological Cancers Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Hematological Cancers Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Hematological Cancers Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Hematological Cancers Major Manufacturers in 2016

4 GLOBAL HEMATOLOGICAL CANCERS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Hematological Cancers Capacity and Growth Rate Analysis
  4.2.2 2016 Hematological Cancers Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Hematological Cancers Sales and Growth Rate Analysis
  4.3.2 2016 Hematological Cancers Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Hematological Cancers Sales Price
  4.4.2 2016 Hematological Cancers Sales Price Analysis (Company Segment)

5 HEMATOLOGICAL CANCERS REGIONAL MARKET ANALYSIS

5.1 North America Hematological Cancers Market Analysis
  5.1.1 North America Hematological Cancers Market Overview
  5.1.2 North America 2012-2017E Hematological Cancers Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Hematological Cancers Sales Price Analysis
  5.1.4 North America 2016 Hematological Cancers Market Share Analysis
5.2 China Hematological Cancers Market Analysis
  5.2.1 China Hematological Cancers Market Overview
  5.2.2 China 2012-2017E Hematological Cancers Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Hematological Cancers Sales Price Analysis
  5.2.4 China 2016 Hematological Cancers Market Share Analysis
5.3 Europe Hematological Cancers Market Analysis
  5.3.1 Europe Hematological Cancers Market Overview
  5.3.2 Europe 2012-2017E Hematological Cancers Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Hematological Cancers Sales Price Analysis
  5.3.4 Europe 2016 Hematological Cancers Market Share Analysis
5.4 Southeast Asia Hematological Cancers Market Analysis
  5.4.1 Southeast Asia Hematological Cancers Market Overview
  5.4.2 Southeast Asia 2012-2017E Hematological Cancers Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Hematological Cancers Sales Price Analysis
  5.4.4 Southeast Asia 2016 Hematological Cancers Market Share Analysis
5.5 Japan Hematological Cancers Market Analysis
  5.5.1 Japan Hematological Cancers Market Overview
  5.5.2 Japan 2012-2017E Hematological Cancers Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Hematological Cancers Sales Price Analysis
  5.5.4 Japan 2016 Hematological Cancers Market Share Analysis
5.6 India Hematological Cancers Market Analysis
  5.6.1 India Hematological Cancers Market Overview
  5.6.2 India 2012-2017E Hematological Cancers Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Hematological Cancers Sales Price Analysis
  5.6.4 India 2016 Hematological Cancers Market Share Analysis

6 GLOBAL 2012-2017E HEMATOLOGICAL CANCERS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Hematological Cancers Sales by Type
6.2 Different Types of Hematological Cancers Product Interview Price Analysis
6.3 Different Types of Hematological Cancers Product Driving Factors Analysis
  6.3.1 Pharmacological Therapies of Hematological Cancers Growth Driving Factor Analysis
  6.3.2 Stem Cell Transplantation of Hematological Cancers Growth Driving Factor Analysis
  6.3.3 Surgery and Radiation Therapy of Hematological Cancers Growth Driving Factor Analysis
  6.3.4 Anemia Treatment of Hematological Cancers Growth Driving Factor Analysis
  6.3.5 Thrombosis Treatment of Hematological Cancers Growth Driving Factor Analysis
  6.3.6 Neutopenia Treatment of Hematological Cancers Growth Driving Factor Analysis
  6.3.7 Symptomatic treatment of Hematological Cancers Growth Driving Factor Analysis

7 GLOBAL 2012-2017E HEMATOLOGICAL CANCERS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Hematological Cancers Consumption by Application
7.2 Different Application of Hematological Cancers Product Interview Price Analysis
7.3 Different Application of Hematological Cancers Product Driving Factors Analysis
  7.3.1 Epidemiology of Hematological Cancers Growth Driving Factor Analysis
  7.3.2 Pathophysiology of Leukemic Stem Cells of Hematological Cancers Growth Driving Factor Analysis
  7.3.3 Kidney Diseases of Hematological Cancers Growth Driving Factor Analysis
  7.3.4 Genetic Diseases of Hematological Cancers Growth Driving Factor Analysis
  7.3.5 Other Diseases of Hematological Cancers Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF HEMATOLOGICAL CANCERS

8.1 Karyopharm Therapeutics
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Karyopharm Therapeutics 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Karyopharm Therapeutics 2016 Hematological Cancers Business Region Distribution Analysis
8.2 Johnson & Johnson
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Johnson & Johnson 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Johnson & Johnson 2016 Hematological Cancers Business Region Distribution Analysis
8.3 Roche Diagnostics A/S
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Roche Diagnostics A/S 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Roche Diagnostics A/S 2016 Hematological Cancers Business Region Distribution Analysis
8.4 AbbVie
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 AbbVie 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 AbbVie 2016 Hematological Cancers Business Region Distribution Analysis
8.5 Novartis
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Novartis 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Novartis 2016 Hematological Cancers Business Region Distribution Analysis
8.6 Kite Pharma
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Kite Pharma 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Kite Pharma 2016 Hematological Cancers Business Region Distribution Analysis
8.7 Celgene Corporation
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Celgene Corporation 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Celgene Corporation 2016 Hematological Cancers Business Region Distribution Analysis
8.8 Abbott Laboratories
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Abbott Laboratories 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Abbott Laboratories 2016 Hematological Cancers Business Region Distribution Analysis
8.9 Beckman Coulter
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Beckman Coulter 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Beckman Coulter 2016 Hematological Cancers Business Region Distribution Analysis
8.10 HemoCue AB
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 HemoCue AB 2016 Hematological Cancers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 HemoCue AB 2016 Hematological Cancers Business Region Distribution Analysis
8.11 C. R. Bard
8.12 Siemens AG
8.13 Sysmex
8.14 Mindray Medical International Limited
8.15 Bio-Rad Laboratories
8.16 The Medicine Company
8.17 Pharmacyclics
8.18 Horiba
8.19 DiagnoCure Inc.
8.20 Astellas Pharma US

9 DEVELOPMENT TREND OF ANALYSIS OF HEMATOLOGICAL CANCERS MARKET

9.1 Global Hematological Cancers Market Trend Analysis
  9.1.1 Global 2017-2022 Hematological Cancers Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Hematological Cancers Sales Price Forecast
9.2 Hematological Cancers Regional Market Trend
  9.2.1 North America 2017-2022 Hematological Cancers Consumption Forecast
  9.2.2 China 2017-2022 Hematological Cancers Consumption Forecast
  9.2.3 Europe 2017-2022 Hematological Cancers Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Hematological Cancers Consumption Forecast
  9.2.5 Japan 2017-2022 Hematological Cancers Consumption Forecast
  9.2.6 India 2017-2022 Hematological Cancers Consumption Forecast
9.3 Hematological Cancers Market Trend (Product Type)
9.4 Hematological Cancers Market Trend (Application)

10 HEMATOLOGICAL CANCERS MARKETING TYPE ANALYSIS

10.1 Hematological Cancers Regional Marketing Type Analysis
10.2 Hematological Cancers International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hematological Cancers by Region
10.4 Hematological Cancers Supply Chain Analysis

11 CONSUMERS ANALYSIS OF HEMATOLOGICAL CANCERS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL HEMATOLOGICAL CANCERS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hematological Cancers
Table Product Specifications of Hematological Cancers
Table Classification of Hematological Cancers
Figure Global Production Market Share of Hematological Cancers by Type in 2016
Figure Pharmacological Therapies Picture
Table Major Manufacturers of Pharmacological Therapies
Figure Stem Cell Transplantation Picture
Table Major Manufacturers of Stem Cell Transplantation
Figure Surgery and Radiation Therapy Picture
Table Major Manufacturers of Surgery and Radiation Therapy
Figure Anemia Treatment Picture
Table Major Manufacturers of Anemia Treatment
Figure Thrombosis Treatment Picture
Table Major Manufacturers of Thrombosis Treatment
Figure Neutopenia Treatment Picture
Table Major Manufacturers of Neutopenia Treatment
Figure Symptomatic treatment Picture
Table Major Manufacturers of Symptomatic treatment
Table Applications of Hematological Cancers
Figure Global Consumption Volume Market Share of Hematological Cancers by Application in 2016
Figure Epidemiology Examples
Table Major Consumers in Epidemiology
Figure Pathophysiology of Leukemic Stem Cells Examples
Table Major Consumers in Pathophysiology of Leukemic Stem Cells
Figure Kidney Diseases Examples
Table Major Consumers in Kidney Diseases
Figure Genetic Diseases Examples
Table Major Consumers in Genetic Diseases
Figure Other Diseases Examples
Table Major Consumers in Other Diseases
Figure Market Share of Hematological Cancers by Regions
Figure North America Hematological Cancers Market Size (Million USD) (2012-2022)
Figure China Hematological Cancers Market Size (Million USD) (2012-2022)
Figure Europe Hematological Cancers Market Size (Million USD) (2012-2022)
Figure Southeast Asia Hematological Cancers Market Size (Million USD) (2012-2022)
Figure Japan Hematological Cancers Market Size (Million USD) (2012-2022)
Figure India Hematological Cancers Market Size (Million USD) (2012-2022)
Table Hematological Cancers Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hematological Cancers in 2016
Figure Manufacturing Process Analysis of Hematological Cancers
Figure Industry Chain Structure of Hematological Cancers
Table Capacity and Commercial Production Date of Global Hematological Cancers Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Hematological Cancers Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Hematological Cancers Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Hematological Cancers Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Hematological Cancers 2012-2017
Figure Global 2012-2017E Hematological Cancers Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Hematological Cancers Market Size (Value) and Growth Rate
Table 2012-2017E Global Hematological Cancers Capacity and Growth Rate
Table 2016 Global Hematological Cancers Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Hematological Cancers Sales (K Units) and Growth Rate
Table 2016 Global Hematological Cancers Sales (K Units) List (Company Segment)
Table 2012-2017E Global Hematological Cancers Sales Price (USD/Unit)
Table 2016 Global Hematological Cancers Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Hematological Cancers 2012-2017E
Figure North America 2012-2017E Hematological Cancers Sales Price (USD/Unit)
Figure North America 2016 Hematological Cancers Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Hematological Cancers 2012-2017E
Figure China 2012-2017E Hematological Cancers Sales Price (USD/Unit)
Figure China 2016 Hematological Cancers Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Hematological Cancers 2012-2017E
Figure Europe 2012-2017E Hematological Cancers Sales Price (USD/Unit)
Figure Europe 2016 Hematological Cancers Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Hematological Cancers 2012-2017E
Figure Southeast Asia 2012-2017E Hematological Cancers Sales Price (USD/Unit)
Figure Southeast Asia 2016 Hematological Cancers Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Hematological Cancers 2012-2017E
Figure Japan 2012-2017E Hematological Cancers Sales Price (USD/Unit)
Figure Japan 2016 Hematological Cancers Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Hematological Cancers 2012-2017E
Figure India 2012-2017E Hematological Cancers Sales Price (USD/Unit)
Figure India 2016 Hematological Cancers Sales Market Share
Table Global 2012-2017E Hematological Cancers Sales (K Units) by Type
Table Different Types Hematological Cancers Product Interview Price
Table Global 2012-2017E Hematological Cancers Sales (K Units) by Application
Table Different Application Hematological Cancers Product Interview Price
Table Karyopharm Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Karyopharm Therapeutics Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Karyopharm Therapeutics Hematological Cancers Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Hematological Cancers Business Region Distribution
Table Roche Diagnostics A/S Information List
Table Product A Overview
Table Product B Overview
Table 2015 Roche Diagnostics A/S Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Diagnostics A/S Hematological Cancers Business Region Distribution
Table AbbVie Information List
Table Product A Overview
Table Product B Overview
Table 2016 AbbVie Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AbbVie Hematological Cancers Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Hematological Cancers Business Region Distribution
Table Kite Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Kite Pharma Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Kite Pharma Hematological Cancers Business Region Distribution
Table Celgene Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2016 Celgene Corporation Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Celgene Corporation Hematological Cancers Business Region Distribution
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Abbott Laboratories Hematological Cancers Business Region Distribution
Table Beckman Coulter Information List
Table Product A Overview
Table Product B Overview
Table 2016 Beckman Coulter Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Beckman Coulter Hematological Cancers Business Region Distribution
Table HemoCue AB Information List
Table Product A Overview
Table Product B Overview
Table 2016 HemoCue AB Hematological Cancers Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 HemoCue AB Hematological Cancers Business Region Distribution
Table C. R. Bard Information List
Table Siemens AG Information List
Table Sysmex Information List
Table Mindray Medical International Limited Information List
Table Bio-Rad Laboratories Information List
Table The Medicine Company Information List
Table Pharmacyclics Information List
Table Horiba Information List
Table DiagnoCure Inc. Information List
Table Astellas Pharma US Information List
Figure Global 2017-2022 Hematological Cancers Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Hematological Cancers Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Hematological Cancers Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Hematological Cancers Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Hematological Cancers Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Hematological Cancers Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Hematological Cancers Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Hematological Cancers Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Hematological Cancers Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Hematological Cancers by Type 2017-2022
Table Global Consumption Volume (K Units) of Hematological Cancers by Application 2017-2022
Table Traders or Distributors with Contact Information of Hematological Cancers by Region